Genmab (Otc) (GMAB)

NASDAQ:GMAB

US Market

GMAB

Genmab

RESEARCH TOOLSreports

Want to see GMAB full AI Analyst Report?

Genmab (GMAB) Ownership - Who Owns Genmab?

785 Followers

Genmab (GMAB) Ownership Overview

0.83% Mutual Funds

5.67% Other Institutional Investors

1.16% ETFs

92.33% Public Companies and

Individual Investors

The ownership structure of Genmab (GMAB) stock is a mix of institutional, retail, and individual investors. Approximately 7.67% of the company’s stock is owned by Institutional Investors, and 92.33% is owned by Public Companies and Individual Investors.

The ownership structure of Genmab (GMAB) stock is a mix of institutional, retail, and individual investors. Approximately 6.83% of the company’s stock is owned by Institutional Investors, 0.83% is owned by Insiders, and 92.33% is owned by Public Companies and Individual Investors.

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Mar 31, 2024	Gallacher Capital Management Llc	xxxxxxxxxxxxx	$584814
Mar 31, 2024	Manning & Napier Advisors Llc	xxxxxxxxxxxxx	$1449
Mar 31, 2024	Moore Capital Management Lp	xxxxxxxxxxxxx	$5680045
Mar 31, 2024	Deerfield Management Company, Lp	xxxxxxxxxxxxx	$66055460

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	3,591,012	Institution	0.58%	90,744,873
	2,808,278	Institution	0.45%	70,965,185
James E. Flynn	2,462,000	Institution	0.39%	62,214,740
	2,337,110	Institution	0.37%	59,058,770
	870,700	Institution	0.14%	22,002,589
	564,047	Institution	0.09%	14,253,468
	414,116	Institution	0.07%	10,464,711
Michael Rockefeller	369,188	Institution	0.06%	9,329,381
	362,815	Institution	0.06%	9,168,335
	258,730	Institution	0.04%	6,538,107

Top Mutual Fund Holders

Holder	# of Shares	Type	% Holding	Value
	2,337,110	Institution	0.37%	59,058,770
	870,700	Institution	0.14%	22,002,589
	414,116	Institution	0.07%	10,464,711
	362,815	Institution	0.06%	9,168,335
	258,730	Institution	0.04%	6,538,107
	193,948	Institution	0.03%	4,901,066
	179,676	Institution	0.03%	4,540,413
	179,130	Institution	0.03%	4,526,615
	137,000	Institution	0.02%	3,461,990
	47,510	Institution	<0.01%	1,200,578

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
iShares Biotechnology ETF	3,495,982	Institution	0.56%	88,343,465
First Trust NYSE Arca Biotechnology Index Fund	2,734,409	Institution	0.44%	69,098,515
Avantis International Equity ETF	523,577	Institution	0.08%	13,293,620
Tema Oncology ETF	165,721	Institution	0.03%	4,207,656
First Trust Hedged BuyWrite Income ETF	62,273	Institution	<0.01%	1,573,639
iShares NASDAQ US Biotechnology UCITS ETF	47,515	Institution	<0.01%	1,200,704
ActivePassive International Equity ETF	35,388	Institution	<0.01%	898,501
Fidelity Nasdaq Composite Index ETF	26,140	Institution	<0.01%	660,558
Avantis International Large Cap Value ETF	17,483	Institution	<0.01%	443,893
Dimensional International Core Equity Market ETF	15,280	Institution	<0.01%	387,959

FAQ

Who Owns Genmab (Otc) (GMAB)?

Currently, no data Available

What percentage of Genmab (Otc) (GMAB) stock is held by institutional investors?

According to the latest TipRanks data, approximately 5.67% of Genmab (Otc) (GMAB) stock is held by institutional investors.

What percentage of Genmab (Otc) (GMAB) stock is held by retail investors?

According to the latest TipRanks data, approximately 92.33% of Genmab (Otc) (GMAB) stock is held by retail investors.

Who owns the most shares of Genmab (Otc) (GMAB)?

iShares owns the most shares of Genmab (Otc) (GMAB).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.